Sumitomo Mitsui DS Asset Management Company Ltd Buys 3,381 Shares of Danaher Corporation $DHR

Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of Danaher Corporation (NYSE:DHR) by 4.0% in the third quarter, Holdings Channel reports. The institutional investor owned 88,853 shares of the conglomerate’s stock after buying an additional 3,381 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Danaher were worth $17,616,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of DHR. WFA of San Diego LLC bought a new position in shares of Danaher in the second quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new stake in Danaher in the 2nd quarter worth approximately $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher in the 3rd quarter worth approximately $28,000. Tripletail Wealth Management LLC bought a new position in Danaher in the 3rd quarter valued at $31,000. Finally, Red Tortoise LLC grew its position in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Up 1.4%

DHR stock opened at $238.28 on Friday. The company has a market capitalization of $168.31 billion, a PE ratio of 49.13, a price-to-earnings-growth ratio of 4.24 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The company’s 50 day moving average price is $225.77 and its two-hundred day moving average price is $210.61.

Danaher (NYSE:DHR) last released its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.71 EPS. As a group, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is 26.39%.

Insider Transactions at Danaher

In other news, Director Teri List sold 3,298 shares of Danaher stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 30,248 shares of company stock worth $6,609,663. Company insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on DHR shares. Barclays increased their price objective on Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. HSBC upped their target price on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research note on Monday, December 1st. Robert W. Baird set a $247.00 price target on Danaher in a research report on Wednesday, October 22nd. Cowen reissued a “buy” rating on shares of Danaher in a report on Wednesday. Finally, Jefferies Financial Group increased their price target on shares of Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Twenty-one equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $249.92.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.